Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

2.

Brain cancer: a Q&A session.

3.

Women are more susceptible to the stress caused by inflation.

4.

Use of social media during pregnancy may increase depression.

5.

A new theranostic drug targets different cancer types.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot